Cite
HARVARD Citation
Schönherr, C. et al. (n.d.). 739PQuality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON. Annals of oncology. p. . [Online].